Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension
Background Pulmonary arterial hypertension (PAH) is a deadly disease without effective non-invasive diagnostic and prognostic testing. It remains unclear whether vasodilators reverse inflammatory activation, a part of PAH pathogenesis. Single-cell profiling of inflammatory cells in blood could clari...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-01-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/11/1/00486-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|